Dr Reddy’s Laboratories Ltd ADR

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$80,162,000
$76,727,000
$76,727,000
$72,148,000
Gross Profit
47,769,000
46,344,000
46,344,000
42,203,000
EBITDA
23,899,000
21,757,000
21,286,000
EBIT
19,924,000
17,947,000
17,516,000
Net Income
12,553,000
13,920,000
13,920,000
13,789,000
Net Change In Cash
80,162,000
76,727,000
76,727,000
72,148,000
Free Cash Flow
1,407,000
2,072,000
2,072,000
-305,000
Cash
11,330,000
4,913,000
4,913,000
7,342,000
Basic Shares
69,738,888
166,545
166,786
166,775

Annual Financials

Values in thousands 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue
$279,164,000
$245,879,000
$214,391,000
$189,722,000
Gross Profit
163,607,000
202,972,000
113,840,000
103,077,000
EBITDA
82,574,000
74,431,000
47,743,000
45,706,000
EBIT
67,733,000
61,795,000
35,919,000
32,910,000
Net Income
55,684,000
45,067,000
23,568,000
17,238,000
Net Change In Cash
279,164,000
245,879,000
214,391,000
189,722,000
Free Cash Flow
17,998,000
40,009,000
9,059,000
23,142,000
Cash
7,107,000
5,779,000
14,852,000
14,829,000
Basic Shares
166,707
166,382
166,338
166,316

Earnings Calls

Quarter EPS
2024-09-30
$0.18
2024-06-30
$83.46
2024-03-31
$78.35
2023-12-31
$82.81